Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinson's Disease in the UK Setting: An Economic Markov Model Evaluation

Author： Haycox Alan  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.26, Iss.9, 2009-09, pp. : 791-801

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinson's Disease in the UK Setting:: An Economic Markov Model Evaluation

By Kovacs Norbert   Janszky Jozsef   Nagy Ferenc  

Drugs & Aging, Vol. 28, Iss. 2, 2011-02 ,pp. : 161-162

Adis International

Access to resources Recommend Favorite

Pramipexole and Levodopa in Early Parkinson's Disease: Dynamic Changes in Cost Effectiveness

By Noyes Katia   Dick Andrew W.   Holloway Robert G.   The Parkinson Study Group  

PharmacoEconomics, Vol. 23, Iss. 12, 2005-01 ,pp. : 1257-1270

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Pramipexole in Parkinson's Disease in the US

By Hoerger T.J.  

PharmacoEconomics, Vol. 14, Iss. 5, 1998-11 ,pp. : 541-557

Adis International

Access to resources Recommend Favorite

A Markov Model of the Cost Effectiveness of Olanzapine Treatment for Agitation and Psychosis in Alzheimer's Disease

By Kirbach Stephanie  

Clinical Drug Investigation, Vol. 28, Iss. 5, 2008-01 ,pp. : 291-303

Adis International

Access to resources Recommend Favorite

Safety of rasagiline for the treatment of Parkinson's disease

By Perez-Lloret Santiago   Rascol Olivier  

Expert Opinion on Drug Safety, Vol. 10, Iss. 4, 2011-07 ,pp. : 633-643

Informa Healthcare

Access to resources Recommend Favorite